Skip to main content

Walk in interview for M.Pharm, B.Pharm, MSc at Jodas Expoim Pvt Ltd

Jodas is a Global, specialty, innovation driven, emerging, generic bio- pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. JEPL is having EU GMP certification of Oncology (orals), Contrast Media (SVP &. LVP) and facility for Cephalosporins (DPI) currently delivering the products like Anti-Cancer and Antibiotics, Contrast media.

Vacancy for Senior Research Fellow at NII

The National Institute of Immunology (NII) is committed to advanced research addressing the basic mechanisms involved in body's defence to identify modalities for manipulation of the immune system to provide protection against diseases and understand mechanisms that can be used to target disease processes for intervention.

Job for Pharmacist at Beemed Pharma Solutions Private Limited

Beemed Pharma Solutions Private Limited is a Private incorporated on 29 January 2019. It is classified as Non-govt company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs. 100,000 and its paid up capital is Rs. 10,000. It is inolved in Other wholesale.

Work as RA CMC Associate Manager at Novartis | B.Pharm, BSc

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Require Regulatory Affairs Assistant Manager at Abbott

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide. 

Momenta Pharmaceuticals Inc (Momenta) announced that it has entered into a definitive agreement with Johnson & Johnson (J&J). According to the agreement, J&J will acquire Momenta for USD 52.50 per share in an all-cash transaction.

Subscribe to